Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies (2022)
- Authors:
- Oliveira, Aldo Sena de - Universidade Federal de Santa Catarina (UFSC)
- Valli, Marilia
- Ferreira, Leonardo Luiz Gomes
- Souza, Julia Medeiros
- Andricopulo, Renata Krogh
- Meier, Lidiane - Universidade Federal de Santa Catarina (UFSC)
- Abreu, Heitor R. - Universidade Federal de Santa Catarina (UFSC)
- Voltolini, Bruna G. - Universidade Federal de Santa Catarina (UFSC)
- Llanes, Luana C.
- Nunes, Ricardo José - Universidade Federal de Santa Catarina (UFSC)
- Braga, Antonio L. - Universidade Federal de Santa Catarina (UFSC)
- Andricopulo, Adriano Defini
- Oliveira, Aldo Sena de - Universidade Federal de Santa Catarina (UFSC)
- USP affiliated authors: ANDRICOPULO, RENATA KROGH - IFSC ; ANDRICOPULO, ADRIANO DEFINI - IFSC ; OLIVEIRA, ALDO SENA DE - IFSC ; VALLI, MARILIA - IFSC ; FERREIRA, LEONARDO LUIZ GOMES - IFSC ; SOUZA, JULIA MEDEIROS - IFSC
- Unidade: IFSC
- DOI: 10.4155/fmc-2022-0013
- Subjects: FÁRMACOS; PLANEJAMENTO DE FÁRMACOS; DOENÇAS PARASITÁRIAS; DOENÇA DE CHAGAS
- Keywords: Chagas disease; QSAR; Chalcones; Cruzain; Molecular docking
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Future Medicinal Chemistry
- ISSN: 1756-8919
- Volume/Número/Paginação/Ano: v. 14, n. 11, p. 795-808, June 2022
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
OLIVEIRA, Aldo Sena de et al. Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies. Future Medicinal Chemistry, v. 14, n. 11, p. 795-808, 2022Tradução . . Disponível em: https://doi.org/10.4155/fmc-2022-0013. Acesso em: 02 maio 2024. -
APA
Oliveira, A. S. de, Valli, M., Ferreira, L. L. G., Souza, J. M., Andricopulo, R. K., Meier, L., et al. (2022). Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies. Future Medicinal Chemistry, 14( 11), 795-808. doi:10.4155/fmc-2022-0013 -
NLM
Oliveira AS de, Valli M, Ferreira LLG, Souza JM, Andricopulo RK, Meier L, Abreu HR, Voltolini BG, Llanes LC, Nunes RJ, Braga AL, Andricopulo AD. Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies [Internet]. Future Medicinal Chemistry. 2022 ; 14( 11): 795-808.[citado 2024 maio 02 ] Available from: https://doi.org/10.4155/fmc-2022-0013 -
Vancouver
Oliveira AS de, Valli M, Ferreira LLG, Souza JM, Andricopulo RK, Meier L, Abreu HR, Voltolini BG, Llanes LC, Nunes RJ, Braga AL, Andricopulo AD. Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies [Internet]. Future Medicinal Chemistry. 2022 ; 14( 11): 795-808.[citado 2024 maio 02 ] Available from: https://doi.org/10.4155/fmc-2022-0013 - Synthesis of 1,2,3-triazole selenides with anti-T. cruzi activity
- Natural products for drug discovery: cytochalasins with antitrypanosomal activity
- DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease
- Structure-activity relationships of novel N-imidazoylpiperazines with potent anti-trypanosoma cruzi activity
- Synthesis and investigation of the trypanocidal potential of novel 1,2,3-triazole-selenide hybrids
- Discovery of highly potent and selective antiparasitic new oxadiazole and hydroxy-oxindole small molecule hybrids
- Identification of natural cytochalasins as leads for neglected tropical diseases drug discovery
- Navigating the chemical space and chemical multiverse of a Unified Latin American Natural Product Database: LANaPDB
- Molecular docking and quantum studies of lawsone dimers derivatives: new investigation of antioxidant behavior and antifungal activity
- Quantitative structure-activity relationships for structurally diverse chemotypes having anti-Trypanosoma cruzi activity
Informações sobre o DOI: 10.4155/fmc-2022-0013 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
